Matthew Felwick > Hogan Lovells International LLP > London, England > Lawyer Profile
Hogan Lovells International LLP Offices
ATLANTIC HOUSE
HOLBORN VIADUCT
LONDON
EC1A 2FG
England
- Firm Profile
- Go to...
Matthew Felwick
Work Department
Life Sciences
Position
Partner
Career
Matthew is a disputes Partner in the Global Product Law practice and is co-chair of our London life sciences team. Whether advising a life science company facing a group action in England or helping a global product manufacturer work through claims across Europe, Matthew’s extensive experience of complex, cross-border litigation means he gets the commercial context and quickly finds the best solution.
Matthew focuses on product liability and commercial disputes in the pharmaceutical, biotech, and medical devices industries. He is also experienced in the manufacturing, oil and gas, tobacco, and consumer goods sectors. Matthew helped one of the world’s leading pharmaceutical companies defend product liability claims and navigate a regulatory investigation following the voluntary withdrawal of a blockbuster product and he defended a global manufacturer to claims across a number of jurisdictions following the supply of products to customers in the life sciences sector. He is currently advising a biotech client on a claim against a CRO regarding the conduct of a large-scale multi-centre Phase III clinical trial.
Matthew has specialist experience required to defend clients from collective actions, having acted in a number of high profile Group Actions in the High Court relating to Vioxx, Blood Products, All Metal Hips, and Niger Delta Oil Spills. He regularly gives litigation and risk management advice to global companies including in respect of coronial inquests, regulatory investigations, and prosecutions and crisis management.
Matthew is described as ‘a rising star’ who ‘combines sharp intelligence with a strong commercial awareness’ by Legal 500 2017 where he is recognised for both Product Liability: defendant and Pharmaceuticals and Biotechnology. Matthew is also recognised as one of the leading product lawyers in the UK by Who’s Who Legal: Product Liability Defence 2017.
Languages
English
Education
B.Sc., University of Edinburgh
L.P.C, Oxford Institute of Legal Practice
Pg.D.L., The College of Law, Guildford
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
(Next Generation Partners)The ‘very strong‘ team at Hogan Lovells International LLP assists a varied client base consisting of healthcare, medical device, and pharmaceutical companies with bet-the-company cases and large licensing transactions. Practice co-head Jane Summerfield has vast regulatory expertise spanning clinical trials to reimbursement issues, with particular emphasis on gene therapies and digital health software. Described as ‘Mr. Realistic‘ by clients, patent litigator and co-head Stephen Bennett regularly assists clients with the defence of patents and supplementary certificate rights, while co-head Matthew Felwick is ‘very technical‘ and has deep knowledge surrounding product liability, often acting in group actions and coroner’s inquests. Rated by clients as ‘one of the best life science lawyers in the industry‘, Penny Powell has extensive expertise in M&A and partnering transactions, and counsel Elise Martin is noted for her experience in assisting clients with international regulation and commercial disputes. Having been promoted to partner in January 2023, Stella Wong utilises her medical background to act in disputes concerning biotec, pharmaceutical, and medical device patents.
London > Insurance > Product liability: defendant
(Leading individuals)Hogan Lovells International LLP advises manufacturers and retailers across all sectors on the full range of product safety, sustainability and liability issues. The practice has experience of issues such as breast implants, nanotechnology, lithium ion batteries and power tools. Valerie Kenyon provides regulatory assistance and product compliance support in addition to working on a number of diesel emissions group actions. She co-heads the team with Matthew Felwick who handles cross-border and multi-party disputes across the life sciences, automotive and tobacco industries. Elise Martin works on medical device issues, while Lookman Rawat is well-versed in the tobacco industries.
Lawyer Rankings
- Leading individuals London > Insurance > Product liability: defendant
- Life sciences and healthcare London > Industry focus
- Next Generation Partners London > Industry focus > Life sciences and healthcare
- Product liability: defendant London > Insurance
Top Tier Firm Rankings
- Public sector > Administrative and public law
- Dispute resolution > Banking litigation: investment and retail
- Corporate and commercial > Commercial contracts
- Dispute resolution > Commercial litigation: premium
- Real estate > Commercial property: corporate occupiers
- Real estate > Commercial property: development
- Risk advisory > Data protection, privacy and cybersecurity
- TMT (technology, media and telecoms) > Fintech
- Crime, fraud and licensing > Fraud: civil
- Projects, energy and natural resources > Infrastructure: Project finance and development
- Insurance > Insurance: corporate and regulatory
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Industry focus > Emerging markets
- Industry focus > Emerging markets
- Industry focus > Life sciences and healthcare
- Investment fund formation and management > Listed funds
- Employment > Pensions (non-contentious)
- Employment > Pensions: dispute resolution
- Insurance > Product liability: defendant
- Real estate > Property litigation
- Finance > Trade finance
Firm Rankings
- Real estate > Commercial property: investment
- Dispute resolution > Competition litigation
- Real estate > Construction: contentious
- Real estate > Construction: non-contentious
- Risk advisory > Corporate governance
- Finance > Corporate restructuring & insolvency
- Corporate and commercial > Corporate tax
- Finance > Derivatives and structured products
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: contentious
- Industry focus > Hospitality and leisure
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- Dispute resolution > International arbitration
- Projects, energy and natural resources > Oil and gas
- Insurance > Professional negligence
- Real estate > Property finance
- Investment fund formation and management > Real estate funds
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Finance > Securitisation
- Finance > Transport finance and leasing
- Finance > Acquisition finance
- Transport > Aviation
- Finance > Bank lending: investment grade debt and syndicated loans
- Finance > Debt capital markets
- Industry focus > Emerging markets
- Employment > Employee share schemes
- Corporate and commercial > Equity capital markets – mid-large cap
- Corporate and commercial > EU and competition: trade, WTO anti-dumping and customs
- Corporate and commercial > Financial services: non-contentious/regulatory
- Employment > Health and safety
- Finance > High yield
- Insurance > Insurance and reinsurance litigation
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Projects, energy and natural resources > Mining and minerals
- Real estate > Planning
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £250m)
- Dispute resolution > Public international law
- Transport > Rail
- Dispute resolution > Tax litigation and investigations
- Corporate and commercial > VAT and indirect tax
- Projects, energy and natural resources > Water
- Investment fund formation and management > Fund finance
- Projects, energy and natural resources > Power (including electricity, nuclear and renewables)
- Investment fund formation and management > Private funds
- Employment > Employers
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- TMT (technology, media and telecoms) > Sport
- Corporate and commercial > Equity capital markets – small-mid cap
- Insurance > Insurance litigation: for policyholders